Patients, n (%) |
148 |
74 (50) |
74 (50) |
|
Ethnicity, n (%) |
Caucasian |
139 (93.92) |
69 (93.24) |
70 (94.59) |
|
African |
6 (4.05) |
2 (2.70) |
4 (5.41) |
|
South American |
3 (2.03) |
3 (4.05) |
0 (0) |
|
Age at diagnosis, mean (SD), years |
46.28 (14.431) |
45.88 (14.461) |
46.68 (14.489) |
|
Evolution at diagnosis, median (IQR), months |
36 (72) |
48 (63) |
36 (57) |
|
Diameter median (IQR), cm |
3 (3) |
2.75 (3.43) |
3.3 (2.5) |
p = 0.029 |
Site (148 tumours), n (%) |
Head and neck |
15 (10.14) |
5 (6.76) |
10 (13.51) |
|
Chest |
31 (20.95) |
18 (24.32) |
13 (17.57) |
|
Abdomen |
16 (10.81) |
8 (10.81) |
8 (10.81) |
|
Upper back |
43 (29.05) |
20 (27.03) |
23 (31.08) |
|
Lower back |
10 (6.76) |
6 (8.11) |
4 (5.41) |
|
Upper extremities |
10 (6.76) |
4 (5.41) |
6 (8.11) |
|
Lower extremities |
23 (15.54) |
13 (17.57) |
10 (13.51) |
|
Distal extremities (forearm 1, foot 5), n (%) |
6 (4.05) |
3 (4.05) |
3 (4.05) |
|
Previous scar, n (%) |
6 (4.05) |
1 (1.35) |
5 (6.76) |
|
Pigmented (Bednar tumour), n (%) |
3 (2.03) |
2 (2.70) |
1 (1.35) |
|
Fibrosarcomatous, n (%) |
16 (10.81) |
6 (8.11) |
10 (13.51) |
|
Recurrence, n (%) |
17 (11.49) |
8 (10.81) |
9 (12.16) |
|